ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstracts tagged "Genomics and Proteomics"

  • Abstract Number: 0024 • ACR Convergence 2023

    Detection of Synovial Signatures in Peripheral Blood of Patients with Rheumatoid Arthritis via a Novel Blood-Based DNA Capture Assay

    Peter C. Taylor1, Jenya Antonova2, Jennifer Geis3, Katharine Dilger3, David Chernoff4, Diana Abdueva3, Nancy Shadick5 and Michael Weinblatt6, 1Nuffield Department of Orthopedics, Rheumatology and Musculoskeletal Sciences, University of Oxford, Oxford, United Kingdom, 2Compass Strategy and Research, Inc., San Francisco, CA, 3Aqtual Inc., Hayward, CA, 4Chernoff Consulting, Sausalito, CA, 5Brigham and Women's Hospital, Boston, MA, 6Harvard Medical School, Waban, MA

    Background/Purpose: In rheumatoid arthritis [RA], synovial biopsies were shown to guide therapy selection1. However, biopsies require special training for clinicians and are semi-invasive for patients.…
  • Abstract Number: 0075 • ACR Convergence 2023

    Proteomic, Transcriptomic, and T-Cell Receptor (TCR) Profiling of Synovial Integrin-Expressing (InEx) T Cells in Axial Spondyloarthritis (axSpA)

    Zoya Qaiyum1, Michael Tang2 and Robert Inman2, 1Krembil Research Institute, Toronto, ON, Canada, 2University Health Network, Toronto, ON, Canada

    Background/Purpose: The strong clinical and genetic associations between axial spondyloarthritis (axSpA) and inflammatory bowel disease (IBD) underscore the pathogenic role of the gut-joint axis. The…
  • Abstract Number: 0874 • ACR Convergence 2023

    RNA-Binding Proteins That Are Highly Expressed and Enriched in Healthy Cartilage but Suppressed in Osteoarthritis

    Hannah Swahn, Merissa Olmer and Martin K Lotz, Scripps Research Institute, La Jolla, CA

    Background/Purpose: RNA-binding proteins (RBPs) have diverse and essential biological functions, but their role in cartilage health and disease is largely unknown. The objectives of this…
  • Abstract Number: 1595 • ACR Convergence 2023

    Pharmacological Modulation of Krüppel-like Factor 4 Reduces the Severity of Experimental Osteoarthritis via Tissue Protection and Regeneration

    Manabu Kawata1, Merissa Olmer2, Kristen Johnson3 and Martin K Lotz2, 1Scripps Research Institute, San Diego, CA, 2Scripps Research Institute, La Jolla, CA, 3CALIBR, La Jolla, CA

    Background/Purpose: Krüppel-like factors (KLFs) are members of the zinc finger family of transcription factors, which includes 17 members in mammals. We found that expression of…
  • Abstract Number: 1644 • ACR Convergence 2023

    The EISER Study: Identifying Microbial Factors Associated with Subclinical Gut Inflammation in Spondyloarthritis Patients

    Alba Boix-Amorós1, Rebecca Blank2, Adam Cantor1, Jesus Sanz3, Ana Gutiérrez-Casbas4, Jordi Gratacos Masmitja5, Iago Rodríguez -Lago6, Elisa Trujillo7, Ignacio Marin-Jimenez8, Zulema Plaza9, Marta Domínguez10, Jose Federico Diaz-Gonzalez11, Juan D Canete12, Jose Scher13 and Jose Clemente1, 1Icahn School of Medicine, New York, NY, 2New York University, New York, NY, 3Hospital Universitario Puerta de Hierro, Majadahonda, Spain, 4Hospital General Universitario Dr. Balmis, Alicante, Spain, 5University Hospital Parc Taulí, Sabadell, Spain, 6Gastroenterology department Hospital Galdakao, Galdakao, Spain, 7Hospital Universitario de Canarias, Santa Cruz de Tenerife, Spain, 8Public Health System, Madrid, Spain, 9Universidad Autónoma de Madrid, Madrid, Spain, 10Sociedad Española de Reumatología, Madrid, Spain, 11Hospital Universitario de Canarias, La Laguna, Spain, 12Hospital Clinic an IDIBAPS, Barcelona, Spain, 13New York University School of Medicine, New York, NY

    Background/Purpose: Nearly 8% of patients with spondyloarthritis (SpA) manifest symptoms that are compatible with active inflammatory bowel disease (IBD), despite not having any previous diagnosis…
  • Abstract Number: 1657 • ACR Convergence 2023

    Mapping the Network of Coordinated Immune Dysregulation in Juvenile Dermatomyositis at Single-cell Resolution

    Gabrielle Rabadam1, Camilla Wibrand2, Emily Flynn1, George Hartoularos1, Yang Sun1, Susan Kim3, Chun Jimmie Ye1, Zev Gartner1, Marina Sirota4 and Jessica Neely1, 1University of California San Francisco, San Francisco, CA, 2Aarhus University, Aarhus, Denmark, and University of California San Francisco, San Francisco, CA, 3UCSF Benioff Children's Hospital, San Francisco, CA, 4Bakar Computational Health Sciences Institute, University of California San Francisco, San Francisco, CA

    Background/Purpose: Juvenile Dermatomyositis (JDM) is a rare multisystem autoimmune condition that involves complex immune responses in both innate and adaptive compartments. Currently, we have a…
  • Abstract Number: 1661 • ACR Convergence 2023

    Spatial Transcriptional Alterations in the Cellular Landscape of Pediatric Scleroderma Skin

    Kathryn Torok1, Ying-Ju Lai2, Zhongli Xu3, Anwesha Sanyal3, Giffin Werner3, Theresa Hutchins3, Claire Cheng3 and Wei Chen3, 1University of Pittsburgh, University of Pittsburgh Medical Center, Pittsburgh, PA, 2University of Pittbsurgh, Pittsburgh, PA, 3University of Pittsburgh, Pittsburgh, PA

    Background/Purpose: Recent single-cell RNA sequencing (scRNA seq) data has been generated across several tissues in autoimmune diseases, helping to understand the cellular and molecular underpinnings…
  • Abstract Number: 1762 • ACR Convergence 2023

    Single-cell RNA Sequencing Analysis and Immune Profiling of Antigen-specific T Cells in Patients with Rheumatoid Arthritis and Healthy Controls

    JING SONG1, Cliff Rims1, Matthew Dufort1, Peter Linsley1, Eddie James2 and Jane Buckner2, 1Benaroya Research Institute, Seattle, WA, 2Benaroya Research Institute at Virginia Mason, Seattle, WA

    Background/Purpose: Single-cell analysis has emerged as a powerful tool for investigating the transcriptomics and T-cell receptor (TCR) diversity in patients with rheumatoid arthritis (RA). However,…
  • Abstract Number: 2342 • ACR Convergence 2023

    Modulation of B Cell and Interferon Pathways by Ianalumab in Patients with Systemic Lupus Erythematosus: Findings from a Phase 2 Clinical Trial

    Aida Santos da Costa1, Thomas Dörner2, Andrea Grioni1, Alexandre Avrameas1, Ulrike Sommer1, Rainer Hillenbrand1, Valeria De Luca1, Enrico Ferrero1, Andre Nogueira da Costa1, Isabelle Isnardi1 and Stephen J Oliver1, 1Novartis Pharma AG, Basel, Switzerland, 2Department of Medicine, Rheumatology and Clinical Immunology, Charité Universitätsmedizin and Deutsches Rheumaforschungszentrum, Berlin, Germany

    Background/Purpose: Ianalumab (VAY736) is an afucosylated monoclonal antibody targeting the B cell activating factor receptor (BAFFR) that depletes B cells via enhanced antibody dependent cellular…
  • Abstract Number: 2540 • ACR Convergence 2023

    The Molecular Stratification of Rheumatoid Arthritis Using High-throughput Technologies Is Directly Associated with Disease Activity and Clinical Response

    Ismael Sanchez-Pareja1, Daniel Toro-Dominguez2, Carlos Perez-Sanchez3, Laura Muñoz-Barrera1, Tomás Cerdó1, Rafaela Ortega Castro4, Jerusalem Calvo5, Marta Rojas6, Pilar Font Ugalde1, Maria del Carmen Abalos-Aguilera7, Desiree Ruiz-Vilchez1, Christian Merlo-Ruiz1, Ivan Arias de la Rosa8, Mª Angeles Aguirre9, Eduardo Collantes Estévez10, Nuria Barbarroja11, Marta Alarcon-Riquelme12, Alejandro Escudero Contreras5 and Chary Lopez-Pedrera13, 1IMIBIC/Reina Sofia Hospital/University of Cordoba, Córdoba, Spain, 2GENYO, Granada, Spain, 3IMIBIC, Córdoba, Spain, 4Hospital Reina Sofía, Cordoba, Spain, 5Reina Sofia University Hospital, Córdoba, Spain, 6Hospital Universitario Reina Sofía, Cordoba, Spain, 7Rheumatology Department, Reina Sofia University Hospital/Maimonides Biomedical Research Institute of Cordoba (IMIBIC), Córdoba, Spain, 8IMIBIC/Reina Sofia Hospital/University of Cordoba. Rheumatology service. Cordoba. Spain, Cordoba, Spain, 9Reina Sofía University Hospital/ Rheumatology Department, Córdoba, Spain, 10Maimonides Biomedical Research Institute of Cordoba (IMIBIC)/University of Cordoba, Cordoba, Spain, 11University of Cordoba, Córdoba, Spain, 12Center for Genomics and Oncological Research (GENYO), Granada, Spain, 13IMIBIC - Reina Sofia Hospital, Córdoba, Spain

    Background/Purpose: Rheumatoid arthritis (RA) is a remarkably heterogeneous autoimmune disease whose clinical outcomes with disease-modifying antirheumatic drugs (DMARDs) remain unpredictable. The aim of this study…
  • Abstract Number: 004 • 2023 Pediatric Rheumatology Symposium

    Analysis of Patients with Juvenile Dermatomyositis Compared to Healthy Controls Using CITE-seq Identifies Differences in Cell Composition and Gene and Epitope Expression

    Camilla Wibrand1, Emily Flynn2, Gabrielle Rabadam2, George Hartoularos2, Yang Sun2, Chun Ye2, Susan Kim3, Marina Sirota2 and Jessica Neely1, 1UCSF, San Francisco, CA, 2University of California, San Francisco, San Francisco, CA, 3UCSF Benioff Children's Hospital, San Francisco, CA

    Background/Purpose: Juvenile dermatomyositis (JDM) is a rare and serious systemic autoimmune condition, and much remains unknown about the pathogenesis, the immune cell types and cell-specific…
  • Abstract Number: 1124 • ACR Convergence 2022

    CD4+ Cytotoxic T Lymphocytes (CTL) Are Present in Sjögren’s Disease Minor Salivary Glands and Associate with Markers of Epithelial Cell Damage near Infiltrates

    Michelle Joachims1, Chuang Li1, Joshua Rusbuldt2, Ben Fowler1, Astrid Rasmussen1, Kiely Grundahl1, R. Hal Scofield3, Kathy Sivils4, Christopher Lessard1 and A. Darise Farris1, 1Oklahoma Medical Research Foundation, Oklahoma City, OK, 2Janssen Pharmaceutical Companies of Johnson & Johnson, Spring House, PA, 3University of Oklahoma Health Sciences Center, Oklahoma City, OK, 4Janssen Research and Development, LLC, Spring House, PA

    Background/Purpose: CD4+ T cells dominate focal lymphocytic infiltrates in Sjögren's disease (SjD), but their differentiation states have remained unclear. Here, we used single cell (sc)RNAseq…
  • Abstract Number: 1125 • ACR Convergence 2022

    Genomics of JAK-STAT Signaling in Venous Thromboembolism

    Stine R Haysen, Ane Langkilde-Lauesen Nielsen, Per Qvist and Tue Kragstrup, Aarhus University, Aarhus, Denmark

    Background/Purpose: Janus kinase inhibitors (JAKi) have been associated with an increased risk of venous thromboembolism (VTE). This concern limits the use of JAKi-based therapy. Hence,…
  • Abstract Number: 1145 • ACR Convergence 2022

    The Prostate Plays a Role in Serum Urate Levels and the Risk of Gout in Men

    Mariana Urquiaga1, Megan Leask1, Nicholas Sumpter1, Brooke Maxwell2, Sara Lewis2, Eric E. Kelley2 and Tony Merriman3, 1University of Alabama at Birmingham, Birmingham, AL, 2West Virginia University, Morgantown, WV, 3University of Otago, Dunedin, New Zealand

    Background/Purpose: Men have higher serum urate (SU) and increased prevalence of gout compared to pre-menopausal women. Xanthine oxidoreductase (XOR), encoded by the XDH gene, is…
  • Abstract Number: 1585 • ACR Convergence 2022

    Decreased Discontinuation and Switching of B/tsDMARD Therapy in RA Patients When Treatment Is Aligned with a Molecular Signature Response Classifier: An Analysis from the Study to Accelerate Information of Molecular Signatures (AIMS)

    Jeffrey Curtis1, Emelly Rusli2, Lixia Zhang2, Christina Le-Short2, Alix Arnaud2, Johanna Withers3 and Sam Asgarian2, 1University of Alabama at Birmingham, Hoover, AL, 2Scipher Medicine Corporation, Waltham, MA, 3Scipher Medicine Corportaion, Waltham, MA

    Background/Purpose: Rheumatoid arthritis (RA) patients with inadequate response to methotrexate often experience trial-and-error treatment selection due to a lack of guidance from clinical guidelines or…
  • « Previous Page
  • 1
  • 2
  • 3
  • 4
  • Next Page »
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology